Recon: Ferring Acquires Microbiome Drug Developer Rebiotix

• Ferring Pharma snags a microbiome platform with Rebiotix buy (Fierce) (Endpoints) (Drug Delivery Business News)
• In rare advisory, surgeon general urges public to carry overdose-reversal medication (STAT) (The Hill) (MedScape) (NPR) (Fortune) (NY Times)
• Lilly's Cyramza succeeds in late-stage liver cancer trial (Reuters) (Fierce) (The Pharma Letter) (BioPharma Dive)
• McKesson accused of skimming profit, harming patients (Modern Healthcare) (Axios) (Law360-$)
• Opioid addiction costs employers $2.6 billion a year for care (CNBC) (Fortune) (VOA)
• Conatus shares slide on emricasan study failure (BioPharma Dive) (Fierce)
• Committee Leaders Release Discussion Draft of Bipartisan Legislation to Address Urgent Opioid Crisis (US HELP Committee) (Summary)
• What's in the Senate's new opioids package (Politico)
• Amgen backs Harvard professors’ ALS startup QurAlis (Fierce) (Endpoints)

• Boehringer breathes new life into “don’t eat me” approach (EP Vantage) (BioPharma Dive) (Endpoints) (Fierce)
• BIO Submission to the China Section 301 Investigation (BIO)
• Hopes rise for Shire sale as Takeda CEO discusses case for deal (Reuters) (The Economist)
• Novo Nordisk buys blood drug licence to boost anaemic biopharma business (Reuters) (FirstWord Pharma) (BioPharma Dive)
• Adjustment of EMA Pharmacovigilance fees for inflation (Regulation (EU) No 658/2014) (EC)
• Evolus touts equal efficacy for its Botox me-too drug in Ph III European/Canadian trials (Endpoints)
• Keytruda’s Catch-22 Situation In India Amid Compliance Questions (Pink Sheet-$)
• EU green light for Chiesi’s Lamzede (PharmaTimes) (Endpoints)
• Takeda to sell Brazil subsidiary (The Pharma Letter)
• Biopharma caught in the crosshairs of U.S.-China trade tussle (Fierce) (WTO Complaint)
• Health Canada and CPSC Release New Draft Guidance Document for Consumer Product Industry (Lexology)

• Payer Power: Why Eli Lilly, Janssen, and Merck Deeply Discount Their Drug Prices (Drug Channels)
• Kaleo expanding access in U.S. to drug to reverse opioid overdose (Reuters)
• Investors smart at ailing pharma deals (Financial Times)
• With the drug industry as its partner, an addiction policy group invites tough questions (STAT)
• Drug makers still have a bad reputation among patient groups (STAT-$)
• Trump administration is urged to override patents on pricey muscular dystrophy drug (STAT-$)
• Creative Minds: Optimizing Radio-Immunotherapy for Cancer (NIH)
• ImmunoRestoration, Inc. Selects Premier Research for Pre-Trial Services (Press)

• Novartis-backed Conatus highlights a silver lining, but PhIIb NASH setback causes whiplash in share price (Endpoints)
• RA Capital jumps into the melee on TTR amyloidosis, backing a $91M development plan for a BridgeBio drug (Endpoints)
• Nordic Nanovector further delays pivotal lymphoma readout, parts company with CEO (Fierce)
• Pfizer, Acadia fund Fox Foundation’s new tool for Parkinson’s clinical studies (Fierce) (Press)
• Unnecessary exclusions shut patients out of clinical trials (STAT)
• Clinical Trials in Medical Center Advertising (JAMA)
• High prevalence of S. pyogenes Cas9-specific T cell sensitization within the adult human population - A balanced effector/regulatory T cell response (bioRxiv)
• First Patient Dosed In Pivotal Biomarker-Guided Phase 3 Study Of First Line Therapy With DB102 + R-CHOP In Patients With High-Risk Diffuse Large B-Cell Lymphoma (Press)

• Repro-Med defeats an appeal from EMed in needle-stick patent case (MassDevice)
• Axonics executes $40M financing to commercialize neuromodulation device (Fierce)
• RefleXion Medical reaps $100M in series C round (Fierce)
• Ascensia looks to expand access to blood glucose monitoring tech for UnitedHealthcare enrollees (Drug Delivery Business News)
• Apple launches Health Records with 39 health systems. How soon will it reach clinical studies? (Fierce)
• This patented 3D printing method could boost medical device innovation (Medical Design & Outsourcing)
• 3 New Settlements Highlight DOJ Scrutiny Of Device Makers (Law360-$)
• Eye implant made from stem cells could halt macular degeneration (Fierce)
• LivaNova Completes Acquisition of TandemLife (Press)
• FDA Clears Automated Vasculitis Test from AESKU (Press)

• JP Morgan CEO Sees Long Timeline, Big Goals for Health Venture (Bloomberg)
• Rural health care is expensive, and Washington isn't helping (Axios)
• The Role of Health Care Practitioners (JAMA)
• Six organizations ask HHS Secretary Azar to take title of 5 patents on Exondys 51, as remedy to failure by inventors to disclose NIH funding (Knowledge Ecology International)
• Science Board to the Food and Drug Administration Advisory Committee; Notice of Meeting (FDA)
• Agency Information Collection Activities; Submission for Office of Management and Budget Review; Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals (FDA)

• FDA Advisory Committee Calendar

• NICE denies multiple sclerosis star Ocrevus on price, thwarting Roche yet again (Fierce)
• Greek prosecutor ratchets up inquiries in Novartis bribery probe: report (Fierce)
• Bulgaria reports H5N8 bird flu outbreak in duck farm (Reuters)
• CurveBeam wins CE Mark for LineUP, InReach ortho CTs (MassDevice) (Press)
• Nox Medical claims win over Natus Medical in EU sensor patent spat (MassDevice)
• Minutes of the Extraordinary Management Board meeting for the building approval process of EMA premises in Amsterdam (EMA)
• Kaiku Health Raises €4.4 Million Series A Financing to Accelerate Its Digital Therapeutics Pipeline Led by Debiopharm and Tesi (Press)

• With Drug Price Cuts Done, MHLW Now Running Ministry-Wide Initiative to Shave Prescriptions (Pharma Japan)

• Drugs sold sans regulator's nod, safety studies (Times of India)

• Adverse events (‘side effects’) reporting survey (TGA)
• Updating an existing Class 1-3 in-house IVD notification (TGA)

• Before voting, understand these facts about health care (Toronto Star)

• The stark disparities in how infectious diseases kill Americans (Axios)
• Monkey study suggests Zika infection in infancy could cause brain damage (STAT)
• Poll: Most Americans wary of those suffering from addiction, despite recognition of medical condition (STAT)
• Fall prevention gets harder when elderly leave hospital (Reuters)
• Taxing Soda and Booze Can Spark Healthy Spiral, Experts Say (Bloomberg)
• Fur-covered robots are the new therapy animal (CNET)